IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 36 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q1 2014. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,000 | -50.0% | 26,000 | 0.0% | 0.00% | -33.3% |
| Q2 2016 | $6,000 | -25.0% | 26,000 | -7.1% | 0.00% | 0.0% |
| Q1 2016 | $8,000 | -20.0% | 28,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $10,000 | -16.7% | 28,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $12,000 | -7.7% | 28,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $13,000 | -7.1% | 28,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $14,000 | -30.0% | 28,000 | 0.0% | 0.00% | -25.0% |
| Q4 2014 | $20,000 | -20.0% | 28,000 | 0.0% | 0.00% | -20.0% |
| Q3 2014 | $25,000 | -19.4% | 28,000 | 0.0% | 0.01% | -16.7% |
| Q2 2014 | $31,000 | -8.8% | 28,000 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $34,000 | +30.8% | 28,000 | 0.0% | 0.01% | +16.7% |
| Q4 2013 | $26,000 | -63.9% | 28,000 | 0.0% | 0.01% | -60.0% |
| Q3 2013 | $72,000 | +33.3% | 28,000 | 0.0% | 0.02% | +7.1% |
| Q2 2013 | $54,000 | – | 28,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Callan Capital, LLC | 70,000 | $65,000 | 0.02% |
| Wellington Shields Capital Management, LLC | 51,000 | $47,000 | 0.01% |
| Ifrah Financial Services, Inc. | 18,500 | $17,000 | 0.01% |
| CHELSEA COUNSEL CO | 28,000 | $26,000 | 0.01% |
| DRW Securities, LLC | 120,000 | $111,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 66,303 | $61,000 | 0.00% |
| OPPENHEIMER & CO INC | 107,000 | $99,000 | 0.00% |
| First Allied Advisory Services, Inc. | 45,000 | $42,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $65,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 160,103 | $148,000 | 0.00% |